A Perth health-technology company born from an Australian-Indian research collaboration.
Research begins with IIT Kharagpur and Fortis Hospital
Ticking Heart founded in Perth
Licence with IIT Kharagpur. First vest designed
First clinical study, Fortis Kolkata. Indian patent granted
Coronary artery disease results presented at EACTS, Lisbon
Bangkok Hospital partnership
Indian subsidiary opens in Chennai. Valvular study presented at EMBC, Copenhagen
Multicentric pilot agreed with Fortis Healthcare
Founder. Serial deep-technology entrepreneur.
Kevin has a track record of start-ups, commercialising novel deep technology into sustainable companies. He has a solid blended background in both technology, as a Professor and former Head of School of Electrical Engineering, Computing and Mathematical Sciences at Curtin University, and in start-up ventures.
He co-founded Xelor Pty Ltd, Sensear Pty Ltd, TheBuzz Corp Pty Ltd, iCetana Ltd, Hearmore Pty Ltd, MobiRoam Pty Ltd, Hearing Again Pty Ltd and Ticking Heart Pty Ltd, and is a founding shareholder of the ASX-listed companies Nuheara Ltd, PainChek Ltd and iCetana Ltd. Kevin is the founder of Ticking Heart Pty Ltd.
Co-inventor of PainChek (ASX listed).
Co-inventor of PainChek (ASX: PCK), AI-enabled medical devices in the form of mobile applications for the assessment of pain in people with moderate to severe dementia and infants. PainChek Adult is now in use in aged care homes in Australia, the United Kingdom, New Zealand and Canada.
Jeff has expertise in pharmacotherapy and clinical trials, having worked in hospital, community and aged-care pharmacy, and academia. He has published over 300 professional and research papers, contributed to 37 books and received research funds in excess of $15M as a lead or co-investigator. He is experienced in preparing international regulatory submissions for medical devices.
Deep-tech entrepreneur and non-executive director. Co-inventor of the Noisy Guts acoustic sensing belt.
Adam is a deep-tech entrepreneur and non-executive director uniquely positioned at the intersection of strategic leadership and frontier technology innovation. He co-invented Noisy Guts, a pioneering wearable acoustic sensing belt that diagnoses gut disorders such as IBS non-invasively using AI.
Adam holds a PhD in microelectronics and completed post-doctoral research at EPFL in Switzerland. His technical leadership spans BrainChip Inc. (ASX: BRN), multiple high-tech startup boards, and strategic directorships across AI, intelligent sensing, and clean energy sectors.
As Chairman of the Hydrogen Society of Australia and Co-Founder of Innovate Australia, he bridges international research and development with Australian deep-tech commercialisation, bringing both the instincts of a seasoned serial entrepreneur and the strategic discipline required of board-level leaders.
International business across India, the Middle East, Europe and Australia.
Ameet Babbar brings a wealth of international experience, with a track record of establishing and managing successful businesses in Oman, Dubai, London and New Delhi. His work extends to facilitating international business relations between India, Europe, the Middle East, Southeast Asia and Australia.
Trained in Design Thinking and Natural Eco-system Analysis, Ameet uses abductive reasoning to address complex challenges in start-ups and mature companies. He leads a design consultancy and teaches at the School of Planning and Architecture in New Delhi, and is an active member of prestigious architectural and landscape societies.
Across product, manufacturing and compliance. Founder at Nuheara.
Chief Operations Officer at Nuheara Ltd. As one of the original founders at Nuheara, David developed the initial prototype products and managed engineering development through to production and worldwide compliance of innovative hearing products. He established international logistics, warehousing and shipping to Europe, Asia, North and South America and the Middle East, and has held senior management positions with Mobilarm, Sensear and Nuheara.
Joint PhD, Curtin University and IIT Kharagpur.
Matthew completed a double degree in Physics and Electrical Engineering in 2022, was on the Vice-Chancellor's merit list and won the Nuheara Prize for Top Student in Signal Processing. He is pursuing a joint PhD through Curtin University and the Indian Institute of Technology Kharagpur focused on biomedical signal processing and AI-based acoustic diagnostics, and leads AI model development and multi-sensor data analysis for the Ticking Heart vest.
Co-founder of Xelor, TheBuzz and MobiRoam.
Dr John Siliquini is a co-founder of Xelor, TheBuzz and MobiRoam. He has over 20 years of industry experience, with eight patents pending and more than 40 journal articles. He has held the positions of Engineering Manager and Chief Technology Officer at Xelor, TheBuzz and MobiRoam, leading software and hardware development and testing. At Siemens he was Principal Engineer leading a multidisciplinary team of electrical, mechanical and software engineers.
Supply chain, logistics and ISO 13485 internal audit.
Jordan has a Bachelor's degree in Business Information Systems and Logistics and Supply Chain Management, a graduate certificate in Supply Chain Management and a Master's degree in Supply Chain Management from Curtin University. He has experience in procurement and logistics at Hearing Again and MobiRoam.
Cardiothoracic surgeon. Leads the Fortis clinical programme.
Dr Mandana is a leading consultant in cardiothoracic and vascular surgery and has performed numerous critical and complex cardiothoracic and vascular surgeries. He performed the first successful heart transplant in eastern India on 21 May 2018 at Fortis Anandapur, Kolkata.
He completed his MS in General Surgery at S.N. Medical College, Rajasthan University, and MCh in Cardiovascular and Thoracic Surgery at Kasturba Medical College and Hospital, Manipal, followed by a fellowship of the European Board of Cardiothoracic Surgeons at the University Hospital of Wales, Cardiff (2000). He is full-time Director of Cardiac Surgery at Fortis Hospital, Anandapur, Kolkata.
Cardiovascular surgeon. Director of Cardiovascular Research.
Dr Permyos earned his MD from Prince of Songkla University, Thailand, in 1990 and a PhD in clinical studies from Melbourne University in 2001, focusing on the radial artery as a conduit for coronary artery bypass grafting. He completed a second PhD in Mathematics at Mahidol University in 2007 and trained in cardiac surgery at the University of Toronto.
He is a cardiovascular and thoracic surgeon at Bangkok Heart Hospital, where he also serves as Director of Cardiovascular Research and an ethics reviewer. His research includes intramyocardial angiogenic cell precursors for cardiomyopathy, off-pump coronary artery bypass grafting and carotid endarterectomy. In 2018 he completed a Fellowship in Research Ethics, collaborating with multiple universities and WHO initiatives.
Cardiothoracic surgery and clinical research.
Javed Rashid earned his MBBS from Kunming Medical University, China, in 2017, and a Master's in Cardiothoracic Surgery from Fujian Medical University in 2022, supported by the CSC scholarship. He gained extensive experience during his internships at Union Hospital, Fujian Medical University, in patient management, surgical assistance and post-operative care.
Fluent in English, Hindi, Bengali and Chinese, Javed's research focuses on microRNA detection for acute kidney injury in cardiac surgery patients.
Professor of Electronics and Communication Engineering.
Professor Yue Rong received his B.E. degree from Shanghai Jiao Tong University and is a Professor of Electronics and Communication Engineering at Curtin University, Australia. His research interests include signal processing for communications, wireless and underwater acoustic communications, applications of linear algebra and optimisation methods, and statistical and array signal processing.
Leads the IIT Kharagpur research collaboration.
Professor Goutam Saha leads the biomedical signal processing research at the Indian Institute of Technology Kharagpur that underpins Ticking Heart's multi-sensor phonocardiogram method for detecting coronary artery disease. The collaboration, which began in 2015, continues through joint research and a joint PhD programme with Curtin University.
Minimal environmental impact.
Accessible healthcare for everyone.
People-first, ethical innovation.
Decisions that put well-being first.
Narrowing of the arteries that supply the heart, caused by plaque. It can lead to chest pain, heart attack or sudden death.
Acoustic sensors capture heart sounds. Machine learning detects the subtle changes caused by narrowed arteries.
Yes. Non-invasive, no radiation, no electrical energy applied to the patient.
Minimal. The vest is simple to fit and the Control Unit shows the result. The result is a screening indication to support referral for further assessment, not a diagnosis.
The person is referred to a doctor for further tests. The vest is a screening tool and does not make a diagnosis.
Not yet. The vest is investigational and not approved for sale. Hospitals interested in pilots can contact us.